Welcome to our dedicated page for BlackRock Capital Allocation Term Trust news (Ticker: BCAT), a resource for investors and traders seeking the latest updates and insights on BlackRock Capital Allocation Term Trust stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BlackRock Capital Allocation Term Trust's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BlackRock Capital Allocation Term Trust's position in the market.
BlackRock Capital Allocation Trust (NYSE: BCAT) has secured a $550 million line of credit from BNP Paribas Prime Brokerage, which can be accessed anytime subject to certain conditions. The 179-day rolling facility allows the Trust to borrow funds at the Overnight Bank Funding Rate plus 0.75%. A security interest in nearly all assets has been granted to BNP. The Trust must maintain asset coverage and pay a commitment fee if utilization dips below 80%. This move is expected to enhance liquidity and support investment strategies.
BlackRock held a conference call on June 24 featuring portfolio managers Rick Rieder and Phil Ruvinsky, discussing the performance and strategies of BlackRock Capital Allocation Trust (NYSE: BCAT) and BlackRock Innovation and Growth Trust (NYSE: BIGZ).
Listeners can access the replay by dialing 888-203-1112, using the passcode 7885364. For more updates, investors are encouraged to visit www.blackrock.com/CEF.
BlackRock will host a conference call on June 24 at 4:00pm ET, featuring portfolio managers Rick Rieder and Phil Ruvinsky from BlackRock Capital Allocation Trust (BCAT) and BlackRock Innovation and Growth Trust (BIGZ). Key topics include Rieder's strategy on unconstrained investments across public and private markets in BCAT, and Ruvinsky's management of the $5 billion raised during BIGZ's March 2021 IPO. Investors can join the call by dialing 855-255-2663 with the Call ID 7885364.
BlackRock released its first-quarter fund commentary for BlackRock Capital Allocation Trust (BCAT), highlighting its strategy of investing in public and private markets across equity and fixed income. The Trust offers a monthly distribution of $0.1041 per share, reflecting a 6.25% distribution rate. Since its IPO in September 2020, BCAT has invested approximately $80 million in private equity and debt, aiming to leverage illiquidity premiums. Key management includes Rick Rieder, CIO of Global Fixed Income. For detailed insights, refer to the linked commentary.
FAQ
What is the current stock price of BlackRock Capital Allocation Term Trust (BCAT)?
What is the market cap of BlackRock Capital Allocation Term Trust (BCAT)?
